AbbVie Down 3% in a Month: Why Holding the Stock Still Makes Sense [Yahoo! Finance]
Revolution Medicines, Inc. (RVMD)
Company Research
Source: Yahoo! Finance
Last week, a report issued by the Wall Street Journal (WSJ) mentioned that AbbVie was in advanced talks to acquire Revolution Medicines. The article stated that AbbVie was nearing a deal that could value Revolution Medicines at around $20 billion or more. However, AbbVie denied the rumors in an emailed statement to Reuters. Thereafter, a Financial Times report stated that Merck MRK was in talks to acquire RVMD in a transaction that could value RVMD for up to $32 billion. However, the report mentioned that MRK and RVMD have not yet finalized the deal, and a potential deal remains several weeks away. Separately, the stock has been muted for the past three months despite a beat-and-raise third quarter, as the Humira loss of exclusivity (LOE), softer sales of oncology drugs and continued weakness in its Aesthetics unit weighed on the stock. However, should investors buy the dip or stay away from the stock for now? Let us properly assess AbbVie's strengths and weaknesses to make a pr
Show less
Read more
Impact Snapshot
Event Time:
RVMD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RVMD alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RVMD alerts
High impacting Revolution Medicines, Inc. news events
Weekly update
A roundup of the hottest topics
RVMD
News
- Revolution Medicines (NASDAQ:RVMD) was given a new $143.00 price target on by analysts at Mizuho.MarketBeat
- JPM 26: Day 1 – drug prices and policy changes drive the agenda [Yahoo! Finance]Yahoo! Finance
- Revolution Medicines declines to comment on M&A speculation at conference [Seeking Alpha]Seeking Alpha
- JPM26: Eli Lilly reportedly eyes €15bn takeover of Abivax [Yahoo! Finance]Yahoo! Finance
- Revolution Medicines: Take The Win And Sell Following Large Move Sparked By Buyout Rumors [Seeking Alpha]Seeking Alpha
RVMD
Earnings
- 11/5/25 - Miss
RVMD
Sec Filings
- 1/9/26 - Form 4
- 1/9/26 - Form 4
- 1/7/26 - Form 144
- RVMD's page on the SEC website